RESUMEN
Inflammatory bowel disease (IBD) afflicted individual and most medications have side-effects. Crataegus pinnatifida (Hawthorn), which is a safe medicine and food homolog plant, has been reported to prevent colitis in murine. Yet the bioactivity component and the underlying molecular mechanism remain unclear. Here, we established a direct link between colitis induced by dextran sulphate sodium (DSS) in mice and polysaccharide HAW1-2 isolated from hawthorn. Our results showed HAW1-2 restored the pathological lesions in colon and inhibited the expression of inflammatory cytokines including IL-1ß, IL-6 and TNF-α. Meanwhile, IKKα/ß, IκBα, NF-κB and the phosphorylation levels were inhibited significantly. These findings suggested HAW1-2 could alleviate the inflammation of colon. Further, we found the composition of gut microbiota was modified and Bacteroides including Alistipes and Odoribacter were significantly enriched. Besides, we showed Alistipes and Odoribacter were positively co-related with acetic acid and propionic acid while were negatively co-related with inflammatory cytokines. Finally, we demonstrated the anti-inflammation activity of HAW1-2 might be induced by acetic acid. Together, the present data revealed HAW1-2 could directly modify the gut microbiota, especially for Bacteroides, and generate SCFAs to inhibit colitis. It also implies microbiota-directed intervention in IBD patients should be particularly given more attention.
Asunto(s)
Colitis/tratamiento farmacológico , Colitis/microbiología , Crataegus/química , Ácidos Grasos Volátiles/metabolismo , Microbioma Gastrointestinal , Polisacáridos/uso terapéutico , Ácido Acético/farmacología , Animales , Antiinflamatorios/farmacología , Bacteroides/efectos de los fármacos , Bacteroides/crecimiento & desarrollo , Línea Celular , Colitis/inducido químicamente , Colitis/patología , Colon/efectos de los fármacos , Colon/microbiología , Colon/patología , Sulfato de Dextran , Microbioma Gastrointestinal/efectos de los fármacos , Inflamación/patología , Masculino , Metaboloma , Ratones Endogámicos C57BL , Modelos Biológicos , FN-kappa B/metabolismo , Polisacáridos/farmacología , Ratas , Transducción de Señal/efectos de los fármacosRESUMEN
BACKGROUND: Intestinal microbiota is a novel drug target of metabolic diseases, especially for those with poor oral bioavailability. Nuciferine, with poor bioavailability, has an anti-hyperlipidemic effect at low dosages. PURPOSE: In the present study, we aimed to explore the role of intestinal microbiota in the anti-hyperlipidemic function of nuciferine and identify the key bacterial targets that might confer the therapeutic actions. METHODS: The contribution of gut microbes in the anti-hyperlipidemic effect of nuciferine was evaluated by conventional and antibiotic-established pseudo-sterile mice. Whole-metagenome shotgun sequencing was used to characterize the changes in microbial communities by various agents. RESULTS: Nuciferine exhibited potent anti-hyperlipidemic and liver steatosis-alleviating effects at the doses of 7.5-30 mg/kg. The beneficial effects of nuciferine were substantially abolished when combined with antibiotics. Metagenomic analysis showed that nuciferine significantly shifted the microbial structure, and the enrichment of Akkermansia muciniphila was closely related to the therapeutic effect of nuciferine. CONCLUSIONS: Our results revealed that gut microbiota played an essential role in the anti-hyperlipidemic effect of nuciferine, and enrichment of Akkermansia muciniphila represented a key mechanism through which nuciferine exerted its therapeutic effects.
Asunto(s)
Aporfinas/farmacología , Microbioma Gastrointestinal/efectos de los fármacos , Hiperlipidemias/tratamiento farmacológico , Hipolipemiantes/farmacología , Intestinos/microbiología , Lípidos/sangre , Akkermansia/efectos de los fármacos , Akkermansia/genética , Akkermansia/crecimiento & desarrollo , Animales , Antibacterianos/farmacología , Bacteroides/efectos de los fármacos , Bacteroides/genética , Bacteroides/crecimiento & desarrollo , Biomarcadores/sangre , Dieta Alta en Grasa , Modelos Animales de Enfermedad , Hiperlipidemias/sangre , Hiperlipidemias/microbiología , Masculino , Metagenoma , Metagenómica , Ratones Endogámicos C57BL , Enfermedad del Hígado Graso no Alcohólico/sangre , Enfermedad del Hígado Graso no Alcohólico/microbiología , Enfermedad del Hígado Graso no Alcohólico/prevención & control , Obesidad/sangre , Obesidad/microbiología , Obesidad/prevención & control , RNA-SeqRESUMEN
Evidence suggests that sex influences the effect of diet on the gut bacterial composition, yet, no studies have been performed assessing dietary fatty acid composition (i.e., fat quality) in this context. This study examined the effect of dietary fat quality on colonic bacterial composition in an aged, genetically-diverse mouse population. CD-1 mice were fed isoenergetic diets consisting of (1) control fat (CO; "Western-style" fat blend), (2) CO supplemented with 30% fish oil, (3) CO supplemented with 30% dairy fat, or (4) CO supplemented with 30% echium oil. Fecal samples were collected at mid-life and aged (reproductively senescent) time points. Overall, the abundance of Bacteroidetes was greater in mice fed echium oil compared to mice fed the control fat. Examination of colonic bacterial relative abundance also revealed sex differences, with 73 bacterial taxa being differentially expressed in males and females. Notably, results showed a strong interactive effect among the diet, sex, and age of mice which influenced colonic bacterial relative abundance and alpha diversity. In males, supplementation of the diet with dairy fat or echium oil caused the abundance of Bacteroidetes and Bacteroides to change with age. Additionally, supplementation of the diet with fish oil induced sex-dependent changes in the alpha diversity of aged mice compared to mid-life. This work supports that sex is a critical factor in colonic bacterial composition of an aged, genetically-heterogenous population. Moreover, this study establishes that the effectiveness of dietary interventions for health maintenance and disease prevention via direct or indirect manipulation of the gut microbiota is likely dependent on an individual's sex, age, and genetic background.
Asunto(s)
Colon/microbiología , Grasas de la Dieta/farmacología , Microbioma Gastrointestinal/efectos de los fármacos , Factores de Edad , Animales , Bacteroides/efectos de los fármacos , Bacteroides/crecimiento & desarrollo , Femenino , Aceites de Pescado/farmacología , Masculino , Ratones , Aceites de Plantas/farmacología , Factores SexualesRESUMEN
Pectic polysaccharides from New Zealand (NZ) spinach (Tetragonia tetragonioides) and karaka berries (Corynocarpus laevigatus) were extracted and analyzed. NZ spinach polysaccharides comprised mostly homogalacturonan (64.4%) and rhamnogalacturonan I (5.8%), with side chains of arabinan (8.1%), galactan (2.2%), and type II arabinogalactan (7.1%); karaka berry polysaccharides comprised homogalacturonan (21.8%) and rhamnogalacturonan I (10.0%), with greater proportions of side chains (arabinan, 15.6%; galactan, 23.8%; and type II arabinogalactan, 19.3%). Screening of gut commensal Bacteroides showed that six were able to grow on the NZ spinach extract, while five were able to grow on the karaka berry extract. Analysis of the polysaccharides remaining after fermentation, by size-exclusion chromatography and constituent sugar analysis, showed that the Bacteroides species that grew on these two substrates showed preferences for the different pectic polysaccharide types. Our data suggest that, to completely degrade and utilize the complex pectin structures found in plants, members of Bacteroides and other bowel bacteria work as metabolic consortia.
Asunto(s)
Aizoaceae/química , Bacteroides/crecimiento & desarrollo , Magnoliopsida/química , Pectinas/metabolismo , Polisacáridos/metabolismo , Bacteroides/metabolismo , Fermentación , Frutas/química , Microbioma Gastrointestinal/fisiología , Nueva Zelanda , Pectinas/análisis , Pectinas/química , Hojas de la Planta/química , Polisacáridos/química , Polisacáridos/aislamiento & purificaciónRESUMEN
Vitamin B12 is a critical nutrient for humans as well as microbes. Due to saturable uptake, high dose oral B12 supplements are largely unabsorbed and reach the distal gut where they are available to interact with the microbiota. The aim of this study was to determine if oral B12 supplementation in mice alters 1) the concentration of B12 and related corrinoids in the distal gut, 2) the fecal microbiome, 3) short chain fatty acids (SCFA), and 4) susceptibility to experimental colitis. C57BL/6 mice (up to 24 animals/group) were supplemented with oral 3.94 µg/ml cyanocobalamin (B12), a dose selected to approximate a single 5 mg supplement for a human. Active vitamin B12 (cobalamin), and four B12-analogues ([ADE]CN-Cba, [2Me-ADE]CN-Cba, [2MeS-ADE]CN-Cba, CN-Cbi) were analyzed in cecal and fecal contents using liquid chromatography/mass spectrometry (LC/MS), in parallel with evaluation of fecal microbiota, cecal SCFA, and susceptibility to dextran sodium sulfate (DSS) colitis. At baseline, active B12 was a minor constituent of overall cecal (0.86%) and fecal (0.44%) corrinoid. Oral B12 supplementation increased active B12 at distal sites by >130-fold (cecal B12 increased from 0.08 to 10.60 ng/mg, fecal B12 increased from 0.06 to 7.81 ng/ml) and reduced microbe-derived fecal corrinoid analogues ([ADE]CN-Cba, [2Me-ADE]CN-Cba, [2MeS-ADE]CN-Cba). Oral B12 had no effect on cecal SCFA. Microbial diversity was unaffected by this intervention, however a selective decrease in Bacteroides was observed with B12 treatment. Lastly, no difference in markers of DSS-induced colitis were detected with B12 treatment.
Asunto(s)
Bacteroides/efectos de los fármacos , Corrinoides/análisis , Suplementos Dietéticos/análisis , Vitamina B 12/administración & dosificación , Complejo Vitamínico B/administración & dosificación , Administración Oral , Animales , Bacteroides/crecimiento & desarrollo , Ciego/química , Colitis/inducido químicamente , Colitis/dietoterapia , Sulfato de Dextran/toxicidad , Ácidos Grasos Volátiles/análisis , Heces/química , Heces/microbiología , Microbioma Gastrointestinal/efectos de los fármacos , Ratones Endogámicos C57BL , Vitamina B 12/farmacología , Complejo Vitamínico B/farmacologíaRESUMEN
Antibiotic treatment, commonly prescribed for bacterial infections, depletes and subsequently causes long-term alterations in intestinal microbiota composition. Knowing the importance of the microbiome in the regulation of bone density, we investigated the effect of postantibiotic treatment on gut and bone health. Intestinal microbiome repopulation at 4-weeks postantibiotic treatment resulted in an increase in the Firmicutes:Bacteroidetes ratio, increased intestinal permeability, and notably reduced femoral trabecular bone volume (approximately 30%, p < 0.01). Treatment with a mucus supplement (a high-molecular-weight polymer, MDY-1001 [MDY]) prevented the postantibiotic-induced barrier break as well as bone loss, indicating a mechanistic link between increased intestinal permeability and bone loss. A link between the microbiome composition and bone density was demonstrated by supplementing the mice with probiotic bacteria. Specifically, Lactobacillus reuteri, but not Lactobacillus rhamnosus GG or nonpathogenic Escherichia coli, reduced the postantibiotic elevation of the Firmicutes:Bacteroidetes ratio and prevented femoral and vertebral trabecular bone loss. Consistent with causing bone loss, postantibiotic-induced dysbiosis decreased osteoblast and increased osteoclast activities, changes that were prevented by both L. reuteri and MDY. These data underscore the importance of microbial dysbiosis in the regulation of intestinal permeability and bone health, as well as identify L. reuteri and MDY as novel therapies for preventing these adverse effects. © 2018 American Society for Bone and Mineral Research.
Asunto(s)
Antibacterianos/efectos adversos , Resorción Ósea , Disbiosis , Microbioma Gastrointestinal/efectos de los fármacos , Limosilactobacillus reuteri , Probióticos/farmacología , Animales , Antibacterianos/farmacología , Bacteroides/clasificación , Bacteroides/crecimiento & desarrollo , Resorción Ósea/inducido químicamente , Resorción Ósea/microbiología , Resorción Ósea/patología , Resorción Ósea/prevención & control , Disbiosis/inducido químicamente , Disbiosis/microbiología , Disbiosis/prevención & control , Firmicutes/clasificación , Firmicutes/crecimiento & desarrollo , Masculino , Ratones , Ratones Endogámicos BALB CRESUMEN
Arabinoxylans are part of dietary fibre and have received attention given their emergent prebiotic character. Four arabinoxylans extracts were obtained from Argentinian soft and hard wheat. In vitro assays were performed to describe the extent to which the extracts from whole wheat flour support selective growth of Bifidobacterium breve and probiotic Lactobacillus reuteri ATCC23272 in a defined media. The prebiotic effect was evaluated by three quantitative scores: relative growth, prebiotic activity score and prebiotic index. For prebiotic index equation the growth of Bacteroides and Clostridium strains was compared to that of bifidobacteria and lactic acid bacteria. All the arabinoxylans extracts supported the growth of Lactobacillus and Bifidobacterium, reaching higher prebiotic activity score values than inulin (0·37 and 0·36 for Lactobacillus and Bifidobacterium respectively). AX2 from soft wheat and AX4 from hard showed similar prebiotic index value to commercial inulin (2·64, 2·52 and 2·22 respectively), and AX3 extract presented higher prebiotic index value (4·09) than the positive control and other prebiotic index reported for arabinoxylans. These extracts could be used as prebiotic, synbiotic compositions or novel food prototypes to treat dysbiosis associated with many diseases. SIGNIFICANCE AND IMPACT OF THE STUDY: The present work demonstrates that AX extracts from Argentinian soft and hard wheat promote efficiently the growth of probiotic strain L. reuteri ATCC23272 and B. breve 286, validated with three different parameters that consider the growth of representative strains of Bacteria genera found in the gut. The evaluation of AX extracts as a food supplement in a murine model could confirm their ability to modulate the microbiome. Novel food prototypes including AX and probiotics could relieve local symptoms and may act as psychobiotics with a beneficial effect on microbiome-brain axis.
Asunto(s)
Bifidobacterium breve/crecimiento & desarrollo , Limosilactobacillus reuteri/crecimiento & desarrollo , Preparaciones de Plantas/farmacología , Triticum/química , Xilanos/farmacología , Bacteroides/crecimiento & desarrollo , Clostridium/crecimiento & desarrollo , Fibras de la Dieta , Prebióticos/microbiología , Probióticos/metabolismo , SimbióticosRESUMEN
Polysaccharides from feijoa fruit were extracted and analyzed; the composition of these polysaccharides conforms to those typically found in the primary cell walls of eudicotyledons. The two major polysaccharide extracts consisted of mainly pectic polysaccharides and hemicellulosic polysaccharides [xyloglucan (77%) and arabinoxylan (16%)]. A collection of commensal Bacteroides species was screened for growth in culture using these polysaccharide preparations and placed into five categories based on their preference for each substrate. Most of the species tested could utilize the pectic polysaccharides, but growth on the hemicellulose was more limited. Constituent sugar and glycosyl linkage analysis showed that species that grew on the hemicellulose fraction showed differences in their preference for the two polysaccharides in this preparation. Our data demonstrate that the members of the genus Bacteroides show differential hydrolysis of pectic polysaccharides, xyloglucan, and arabinoxylan, which might influence the structure and metabolic activities of the microbiota in the human gut.
Asunto(s)
Bacteroides/crecimiento & desarrollo , Feijoa/química , Microbioma Gastrointestinal/efectos de los fármacos , Extractos Vegetales/química , Bacteroides/metabolismo , Feijoa/metabolismo , Frutas/química , Frutas/metabolismo , Humanos , Extractos Vegetales/metabolismo , SimbiosisRESUMEN
The suitability of artichoke and sunflower by-products as renewable sources of pectic compounds with prebiotic potential was evaluated by studying their ability to modulate the human faecal microbiota in vitro. Bacterial populations and short-chain fatty acid (SCFA) production were measured. Reduction of the molecular weight of artichoke pectin resulted in greater stimulation of the growth of Bifidobacterium, Lactobacillus and Bacteroides/Prevotella, whilst this effect was observed only in Bacteroides/Prevotella for sunflower samples. In contrast, the degree of methoxylation did not have any impact on fermentability properties or SCFA production, regardless of the origin of pectic compounds. Although further in vivo studies should be conducted, either pectin or enzymatically-modified pectin from sunflower and artichoke by-products might be considered as prebiotic candidates for human consumption showing similar ability to promote the in vitro growth of beneficial gut bacteria as compared to well-recognized prebiotics such as inulin or fructo-oligosaccharides.
Asunto(s)
Fermentación , Pectinas/metabolismo , Adulto , Bacteroides/crecimiento & desarrollo , Bacteroides/metabolismo , Bifidobacterium/crecimiento & desarrollo , Bifidobacterium/metabolismo , Citrus/química , Cynara scolymus/química , Enterococcus/crecimiento & desarrollo , Enterococcus/metabolismo , Eubacterium/crecimiento & desarrollo , Eubacterium/metabolismo , Ácidos Grasos Volátiles/análisis , Heces/microbiología , Femenino , Microbioma Gastrointestinal/efectos de los fármacos , Helianthus/química , Humanos , Lactobacillus/crecimiento & desarrollo , Lactobacillus/metabolismo , Masculino , Pectinas/química , Pectinas/aislamiento & purificación , Prebióticos , Prevotella/crecimiento & desarrollo , Prevotella/metabolismoRESUMEN
The major nutrients available to human colonic Bacteroides species are glycans, exemplified by pectins, a network of covalently linked plant cell wall polysaccharides containing galacturonic acid (GalA). Metabolism of complex carbohydrates by the Bacteroides genus is orchestrated by polysaccharide utilization loci (PULs). In Bacteroides thetaiotaomicron, a human colonic bacterium, the PULs activated by different pectin domains have been identified; however, the mechanism by which these loci contribute to the degradation of these GalA-containing polysaccharides is poorly understood. Here we show that each PUL orchestrates the metabolism of specific pectin molecules, recruiting enzymes from two previously unknown glycoside hydrolase families. The apparatus that depolymerizes the backbone of rhamnogalacturonan-I is particularly complex. This system contains several glycoside hydrolases that trim the remnants of other pectin domains attached to rhamnogalacturonan-I, and nine enzymes that contribute to the degradation of the backbone that makes up a rhamnose-GalA repeating unit. The catalytic properties of the pectin-degrading enzymes are optimized to protect the glycan cues that activate the specific PULs ensuring a continuous supply of inducing molecules throughout growth. The contribution of Bacteroides spp. to metabolism of the pectic network is illustrated by cross-feeding between organisms.
Asunto(s)
Bacteroides/metabolismo , Colon/microbiología , Dieta , Pectinas/metabolismo , Polisacáridos/metabolismo , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Bacteroides/enzimología , Bacteroides/genética , Bacteroides/crecimiento & desarrollo , Genes Bacterianos/genética , Glicósido Hidrolasas , Ácidos Hexurónicos , Humanos , Mutagénesis Sitio-Dirigida , Células Vegetales/metabolismoRESUMEN
The bactericidal lectin RegIIIß is inducibly produced by intestinal epithelial cells as a defense against infection by enteropathogens. In the gut lumen, RegIIIß kills not only certain enteropathogens, but also some commensal bacteria; thus, RegIIIß is also thought to be an innate immune effector shaping microbiota composition and establishing intestinal homeostasis. Using the streptomycin mouse model for Salmonella colitis, we show that RegIIIß can promote sustained gut colonization of Salmonella Typhimurium and prolong enteropathy. RegIIIß expression was associated with suppression of Bacteroides spp. in the gut lumen, prolonged disease-associated alterations in colonic metabolism, and reduced luminal vitamin B6 levels. Supplementation with Bacteroides spp. or vitamin B6 accelerated pathogen clearance from the gut and remission of enteropathy. Our findings indicate that interventions at the level of RegIIIß and supplementation with Bacteroides spp. or vitamin B6 might open new avenues for therapeutic intervention in the context of Salmonella colitis.
Asunto(s)
Antibacterianos/farmacología , Colitis/tratamiento farmacológico , Lectinas/farmacología , Salmonelosis Animal/tratamiento farmacológico , Animales , Bacteroides/crecimiento & desarrollo , Colitis/microbiología , Colon/microbiología , Diarrea/tratamiento farmacológico , Diarrea/microbiología , Modelos Animales de Enfermedad , Microbioma Gastrointestinal , Metabolómica , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Probióticos/administración & dosificación , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Salmonelosis Animal/microbiología , Salmonella enterica/efectos de los fármacos , Salmonella enterica/crecimiento & desarrollo , Estreptomicina , Vitamina B 6/administración & dosificaciónRESUMEN
AIMS: To examine whether co-administration of intestinal alkaline phosphatase (IAP) with antibiotics early in life may have a preventive role against metabolic syndrome (MetS) in mice. METHODS: A total of 50 mice were allocated to four treatment groups after weaning. Mice were treated with azithromycin (AZT) ± IAP, or with no AZT ± IAP, for three intermittent 7-day cycles. After the last treatment course, the mice were administered a regular chow diet for 5 weeks and subsequently a high-fat diet for 5 weeks. Body weight, food intake, water intake, serum lipids, glucose levels and liver lipids were compared. 16S rRNA gene pyrosequencing was used to determine the differences in microbiome composition. RESULTS: Exposure to AZT early in life rendered mice susceptible to MetS in adulthood. Co-administration of IAP with AZT completely prevented this susceptibility by decreasing total body weight, serum lipids, glucose levels and liver lipids to the levels of control mice. These effects of IAP probably occur as a result of changes in the composition of specific bacterial taxa at the genus and species levels (e.g. members of Anaeroplasma and Parabacteroides). CONCLUSIONS: Co-administration of IAP with AZT early in life prevents mice from susceptibility to the later development of MetS. This effect is associated with alterations in the composition of the gut microbiota. IAP may represent a novel treatment against MetS in humans.
Asunto(s)
Fosfatasa Alcalina/uso terapéutico , Antibacterianos/efectos adversos , Azitromicina/efectos adversos , Suplementos Dietéticos , Disbiosis/prevención & control , Mucosa Intestinal/enzimología , Síndrome Metabólico/prevención & control , Acholeplasma/clasificación , Acholeplasma/efectos de los fármacos , Acholeplasma/crecimiento & desarrollo , Acholeplasma/aislamiento & purificación , Fosfatasa Alcalina/efectos adversos , Animales , Bacteroides/clasificación , Bacteroides/efectos de los fármacos , Bacteroides/crecimiento & desarrollo , Bacteroides/aislamiento & purificación , Bovinos , Dieta Alta en Grasa/efectos adversos , Suplementos Dietéticos/efectos adversos , Disbiosis/inducido químicamente , Disbiosis/microbiología , Disbiosis/fisiopatología , Heces/microbiología , Microbioma Gastrointestinal/efectos de los fármacos , Masculino , Síndrome Metabólico/complicaciones , Síndrome Metabólico/etiología , Síndrome Metabólico/microbiología , Ratones Endogámicos C57BL , Tipificación Molecular , Obesidad/complicaciones , Obesidad/etiología , Obesidad/microbiología , Obesidad/prevención & control , Destete , Aumento de Peso/efectos de los fármacosRESUMEN
BACKGROUND: Dietary intake of specific non-digestible carbohydrates (including prebiotics) is increasingly seen as a highly effective approach for manipulating the composition and activities of the human gut microbiota to benefit health. Nevertheless, surprisingly little is known about the global response of the microbial community to particular carbohydrates. Recent in vivo dietary studies have demonstrated that the species composition of the human faecal microbiota is influenced by dietary intake. There is now potential to gain insights into the mechanisms involved by using in vitro systems that produce highly controlled conditions of pH and substrate supply. RESULTS: We supplied two alternative non-digestible polysaccharides as energy sources to three different human gut microbial communities in anaerobic, pH-controlled continuous-flow fermentors. Community analysis showed that supply of apple pectin or inulin resulted in the highly specific enrichment of particular bacterial operational taxonomic units (OTUs; based on 16S rRNA gene sequences). Of the eight most abundant Bacteroides OTUs detected, two were promoted specifically by inulin and six by pectin. Among the Firmicutes, Eubacterium eligens in particular was strongly promoted by pectin, while several species were stimulated by inulin. Responses were influenced by pH, which was stepped up, and down, between 5.5, 6.0, 6.4 and 6.9 in parallel vessels within each experiment. In particular, several experiments involving downshifts to pH 5.5 resulted in Faecalibacterium prausnitzii replacing Bacteroides spp. as the dominant sequences observed. Community diversity was greater in the pectin-fed than in the inulin-fed fermentors, presumably reflecting the differing complexity of the two substrates. CONCLUSIONS: We have shown that particular non-digestible dietary carbohydrates have enormous potential for modifying the gut microbiota, but these modifications occur at the level of individual strains and species and are not easily predicted a priori. Furthermore, the gut environment, especially pH, plays a key role in determining the outcome of interspecies competition. This makes it crucial to put greater effort into identifying the range of bacteria that may be stimulated by a given prebiotic approach. Both for reasons of efficacy and of safety, the development of prebiotics intended to benefit human health has to take account of the highly individual species profiles that may result.
Asunto(s)
Fibras de la Dieta/microbiología , Microbioma Gastrointestinal , Inulina/metabolismo , Pectinas/metabolismo , Bacteroides/crecimiento & desarrollo , Bacteroides/aislamiento & purificación , Reactores Biológicos , Fibras de la Dieta/metabolismo , Eubacterium/crecimiento & desarrollo , Eubacterium/aislamiento & purificación , Ácidos Grasos/metabolismo , Fermentación , Firmicutes/crecimiento & desarrollo , Firmicutes/aislamiento & purificación , Humanos , Concentración de Iones de Hidrógeno , ARN Ribosómico 16S/análisisRESUMEN
An anthroposophic lifestyle, which has been associated with reduced allergy risk in children, has several characteristics that could influence gut microbiota. This study aimed to investigate the impact of anthroposophic lifestyle as well as specific early life exposures on the gut microbiota. In total, 665 stool samples from 128 mother-infant pairs from the ALADDIN birth cohort study were included. Samples collected from infants at ages 6 days, 3 weeks, 2 months and 6 months, and from their mothers before and after delivery, respectively, were analyzed using 454-pyrosequencing. Information regarding lifestyle exposures was collected prospectively through interviews and questionnaires. Six-month-old infants in anthroposophic families had a significantly higher abundance of Bifidobacterium and lower abundances of Bacteroides and Veillonella. Caesarean section and breastfeeding had a significant impact on the microbiota: caesarean section was primarily associated with delayed colonization of Bifidobacterium and Bacteroides, whereas breastfed children had a higher relative abundance of Bifidobacterium and a lower abundance of Clostridiales. However, despite large differences in lifestyle exposures, we determined no significant differences in the gut microbiota between the anthroposophic and non-anthroposophic mothers or their infants' before 6 months of age.
Asunto(s)
Intestinos/microbiología , Estilo de Vida , Microbiota/fisiología , Relaciones Madre-Hijo , Adulto , Bacteroides/crecimiento & desarrollo , Bacteroides/aislamiento & purificación , Secuencia de Bases , Bifidobacterium/crecimiento & desarrollo , Bifidobacterium/aislamiento & purificación , Lactancia Materna , Cesárea , Clostridium/crecimiento & desarrollo , Estudios de Cohortes , Heces/microbiología , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Embarazo , Estudios Prospectivos , Análisis de Secuencia de ADN , Encuestas y Cuestionarios , Veillonella/crecimiento & desarrollo , Veillonella/aislamiento & purificaciónRESUMEN
Fecal microbiota transplantation (FMT) is recognized as an alternative therapeutic modality for recurrent Clostridium difficile infection (RCDI); however, data on its efficacy in children are lacking, including its effect on their growth and fecal microbiota. We report on 2 young children (<3 years old) who failed available therapeutics for RCDI, but responded remarkably well to FMT. Besides resolution of clinical features of C difficile infection (CDI), FMT administration led to marked improvement in their growth, along with increased microbiota diversity, especially proportion of Bacteroides. Our 2 cases illustrate the efficacy of FMT in children with RCDI and its positive effect on their growth and gut microbiota.
Asunto(s)
Terapia Biológica , Clostridioides difficile , Infecciones por Clostridium/terapia , Heces/microbiología , Crecimiento , Intestinos/microbiología , Microbiota , Bacteroides/crecimiento & desarrollo , Preescolar , Clostridioides difficile/crecimiento & desarrollo , Infecciones por Clostridium/microbiología , Humanos , Lactante , Masculino , Resultado del TratamientoRESUMEN
The global prevalence of Fe deficiency is high and a common corrective strategy is oral Fe supplementation, which may affect the commensal gut microbiota and gastrointestinal health. The aim of the present study was to investigate the impact of different dietary Fe concentrations on the gut microbiota and gut health of rats inoculated with human faecal microbiota. Rats (8 weeks old, n 40) were divided into five (n 8 each) groups and fed diets differing only in Fe concentration during an Fe-depletion period (12 weeks) and an Fe-repletion period (4 weeks) as follows: (1) Fe-sufficient diet throughout the study period; (2) Fe-sufficient diet followed by 70 mg Fe/kg diet; (3) Fe-depleted diet throughout the study period; (4) Fe-depleted diet followed by 35 mg Fe/kg diet; (5) Fe-depleted diet followed by 70 mg Fe/kg diet. Faecal and caecal samples were analysed for gut microbiota composition (quantitative PCR and pyrosequencing) and bacterial metabolites (HPLC), and intestinal tissue samples were investigated histologically. Fe depletion did not significantly alter dominant populations of the gut microbiota and did not induce Fe-deficiency anaemia in the studied rats. Provision of the 35 mg Fe/kg diet after feeding an Fe-deficient diet significantly increased the abundance of dominant bacterial groups such as Bacteroides spp. and Clostridium cluster IV members compared with that of an Fe-deficient diet. Fe supplementation increased gut microbial butyrate concentration 6-fold compared with Fe depletion and did not affect histological colitis scores. The present results suggest that Fe supplementation enhances the concentration of beneficial gut microbiota metabolites and thus may contribute to gut health.
Asunto(s)
Bacteroides/crecimiento & desarrollo , Clostridium/crecimiento & desarrollo , Colitis/prevención & control , Colon/microbiología , Suplementos Dietéticos , Modelos Animales de Enfermedad , Hierro de la Dieta/uso terapéutico , Animales , Bacteroides/inmunología , Bacteroides/aislamiento & purificación , Bacteroides/metabolismo , Biomarcadores/metabolismo , Ácido Butírico/metabolismo , Ciego/crecimiento & desarrollo , Ciego/inmunología , Ciego/metabolismo , Ciego/microbiología , Niño , Clostridium/inmunología , Clostridium/aislamiento & purificación , Clostridium/metabolismo , Colitis/inmunología , Colitis/metabolismo , Colitis/microbiología , Colon/crecimiento & desarrollo , Colon/inmunología , Colon/metabolismo , Suplementos Dietéticos/efectos adversos , Heces/química , Heces/microbiología , Femenino , Vida Libre de Gérmenes , Humanos , Íleon/crecimiento & desarrollo , Íleon/inmunología , Íleon/metabolismo , Íleon/microbiología , Inmunidad Mucosa , Hierro/administración & dosificación , Hierro/análisis , Deficiencias de Hierro , Hierro de la Dieta/efectos adversos , Hierro de la Dieta/análisis , Hierro de la Dieta/metabolismo , Ratas , Ratas Endogámicas F344 , Aumento de PesoRESUMEN
AIM: Establishment of ruminal bacterial community in dairy calves. METHODS AND RESULTS: Rumen bacterial community was analysed on 6 calves bred according to commercial practices from day one to weaning at day 83 of age, using 454 16S rRNA-based pyrosequencing. Samples taken at day 1 did not produce amplicons. Analysis of data revealed a three-stage implantation process with a progressive but important shift of composition. At day 2, the bacterial community was mainly composed of Proteobacteria (70%) and Bacteroidetes (14%), and Pasteurellaceae was the dominant family (58%). The bacterial community abruptly changed between days 2 and 3, and until day 12, dominant genera were Bacteroides (21%), Prevotella (11%), Fusobacterium (5%) and Streptococcus (4%). From 15 to 83 days, when solid food intake rapidly increased, Prevotella became dominant (42%) and many genera strongly decreased or were no longer detected. A limited number of bacteria genera correlated with feed intake, rumen volatile fatty acids and enzymatic activities. CONCLUSION: The ruminal bacterial community is established before intake of solid food, but solid food arrival in turn shapes this community. SIGNIFICANCE AND IMPACT OF THE STUDY: This study provides insight into the establishment of calves' rumen bacterial community and suggests a strong effect of diet.
Asunto(s)
Bacterias/crecimiento & desarrollo , Dieta/veterinaria , Rumen/microbiología , Animales , Animales Recién Nacidos , Animales Lactantes , Bacterias/clasificación , Bacterias/genética , Bacteroides/clasificación , Bacteroides/genética , Bacteroides/crecimiento & desarrollo , Bacteroidetes/clasificación , Bacteroidetes/genética , Bacteroidetes/crecimiento & desarrollo , Bovinos , Calostro/microbiología , ADN Bacteriano/química , ADN Ribosómico/química , Dieta/clasificación , Ácidos Grasos Volátiles/análisis , Femenino , Fusobacterium/clasificación , Fusobacterium/genética , Fusobacterium/crecimiento & desarrollo , Masculino , Pasteurellaceae/clasificación , Pasteurellaceae/genética , Pasteurellaceae/crecimiento & desarrollo , Prevotella/clasificación , Prevotella/genética , Prevotella/crecimiento & desarrollo , Proteobacteria/clasificación , Proteobacteria/genética , Proteobacteria/crecimiento & desarrollo , ARN Bacteriano/genética , ARN Ribosómico 16S/genética , Rumen/enzimología , Rumen/metabolismo , Streptococcus/clasificación , Streptococcus/genética , Streptococcus/crecimiento & desarrollo , DesteteRESUMEN
Eleutherine americana extract and its oligosaccharides extract were demonstrated for their growth-promoting activities on mixed infant intestinal microbiota and individual bacterial species including Bacteroides, bifidobacteria, clostridia, and lactobacilli. Fermentation of all the substrates resulted in about 1-2 log increase in the numbers of bifidobacteria belonging to the dominant infant gut microbiota. The highest levels of the bacterial populations were resulted from the oligosaccharides extract. The oligosaccharides extract stimulated the growth of bifidobacteria in mixed and individual populations by increasing their numbers from 9.63 to 12.08 and 5.80 to 8.85 log cfu/ml, respectively within 48 h. In addition, Bacteroides populations were enhanced by fermentation of E. americana extract. Increase in lactobacilli level was observed from fermentation by a single bacterial species, but not from the mixed cultures. Fermentation of the extract, oligosaccharides extract, and commercial fructo-oligosaccharides by both mixed and individual intestinal microbiota resulted in increase in the production of short chain fatty acids. Acetic acid production was predominant, followed by lactic acid and minor amount of propionic and butyric acids. The highest production of acetic acid was resulted from the oligosaccharides extract. Increase in the acetic acid in mixed and individual species of bifidobacterial populations ranged from 1.21 to 34.26 and 1.02-25.21 mM, respectively. This study showed that E. americana can be considered as a potential prebiotic which may be supplemented as an ingredient in functional foods.
Asunto(s)
Intestinos/microbiología , Iridaceae/química , Metagenoma/fisiología , Oligosacáridos/metabolismo , Prebióticos , Bacteroides/efectos de los fármacos , Bacteroides/crecimiento & desarrollo , Bifidobacterium/efectos de los fármacos , Bifidobacterium/crecimiento & desarrollo , Clostridium/crecimiento & desarrollo , Ácidos Grasos Volátiles/metabolismo , Heces/microbiología , Fermentación , Humanos , Lactante , Lactobacillus/efectos de los fármacos , Lactobacillus/crecimiento & desarrollo , Oligosacáridos/farmacología , Extractos Vegetales/química , Extractos Vegetales/metabolismoAsunto(s)
Antioxidantes/farmacología , Extractos Vegetales/farmacología , Prebióticos , Selenio/farmacología , Té/química , Animales , Antibacterianos/farmacología , Antineoplásicos/farmacología , Bacteroides/efectos de los fármacos , Bacteroides/crecimiento & desarrollo , Bifidobacterium/efectos de los fármacos , Bifidobacterium/crecimiento & desarrollo , Clostridium/efectos de los fármacos , Clostridium/crecimiento & desarrollo , Glucuronidasa/antagonistas & inhibidores , Glucuronidasa/metabolismo , Humanos , Lactobacillaceae/efectos de los fármacos , Lactobacillaceae/crecimiento & desarrollo , RatasRESUMEN
Symbiotic bacteria inhabiting the human gut have evolved under intense pressure to utilize complex carbohydrates, primarily plant cell wall glycans in our diets. These polysaccharides are not digested by human enzymes, but are processed to absorbable short chain fatty acids by gut bacteria. The Bacteroidetes, one of two dominant bacterial phyla in the adult gut, possess broad glycan-degrading abilities. These species use a series of membrane protein complexes, termed Sus-like systems, for catabolism of many complex carbohydrates. However, the role of these systems in degrading the chemically diverse repertoire of plant cell wall glycans remains unknown. Here we show that two closely related human gut Bacteroides, B. thetaiotaomicron and B. ovatus, are capable of utilizing nearly all of the major plant and host glycans, including rhamnogalacturonan II, a highly complex polymer thought to be recalcitrant to microbial degradation. Transcriptional profiling and gene inactivation experiments revealed the identity and specificity of the polysaccharide utilization loci (PULs) that encode individual Sus-like systems that target various plant polysaccharides. Comparative genomic analysis indicated that B. ovatus possesses several unique PULs that enable degradation of hemicellulosic polysaccharides, a phenotype absent from B. thetaiotaomicron. In contrast, the B. thetaiotaomicron genome has been shaped by increased numbers of PULs involved in metabolism of host mucin O-glycans, a phenotype that is undetectable in B. ovatus. Binding studies of the purified sensor domains of PUL-associated hybrid two-component systems in conjunction with transcriptional analyses demonstrate that complex oligosaccharides provide the regulatory cues that induce PUL activation and that each PUL is highly specific for a defined cell wall polymer. These results provide a view of how these species have diverged into different carbohydrate niches by evolving genes that target unique suites of available polysaccharides, a theme that likely applies to disparate bacteria from the gut and other habitats.